Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.25%
#2 Mubarak Mubarak +44.33%
#3 Pons Pons +44.07%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.27%
#5 Starpower Starpower +28.10%
#6 SkyAI SkyAI +24.07%
#7 TENDIES TENDIES +23.33%
#8 Decred Decred +20.80%
#9 StonkBroker StonkBroker +20.34%
#10 Ocean Protocol Ocean Protocol +19.46%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Clasificación en acciones #29362
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Precio por acción
$0.365
Última sincronización: 2025-08-01
Capitalización bursátil
$21.54M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Elevation Oncology, Inc. (ELEV)

Categoría

Healthcare
Ratio P/S de Elevation Oncology, Inc. (ELEV)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Elevation Oncology, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Elevation Oncology, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH